IMAGE

Figure 3

ID
ZDB-IMAGE-211029-213
Source
Figures for Dona et al., 2021
Image
Figure Caption

Figure 3

Survival in WT siblings (A,B), heterozygous sdhb mutants (C,D), and homozygous sdhb mutants (E,F) presented for control (0 mg⋅L−1 green, blue, and red lines, respectively); low dosage ((A,C,E) 20 mg⋅L−1, purple line) and high dosage ((B,D,F) 500 mg⋅L−1, orange line; 1000 mg⋅L−1, grey line) Vitamin-C-treated larvae. (A,C,E) Survival rate (%) was not significantly prolonged after the low-dosage treatment of Vitamin C sdhb larvae compared to control (E3 medium supplemented; 0 mg⋅L−1) larvae (control: n = 95 homozygous sdhb larvae, n = 126 heterozygous sdhb larvae, and n = 85 WT larvae; 20 mg⋅L−1 Vitamin C: n = 112 homozygous sdhb larvae, n = 190 heterozygous sdhb larvae, and n = 91 WT larvae from two replicates). (B,D,F) Survival rate (%) was significantly reduced in homozygous sdhb mutants after treatment with high dosages of Vitamin C (500 and 1000 mg⋅L−1) compared to control (E3 medium supplemented) larvae (control: n = 72 homozygous sdhb larvae, n = 198 heterozygous sdhb larvae, and n = 87 WT larvae; 500 mg⋅L−1 Vitamin C: n = 84 homozygous sdhb larvae, n = 195 heterozygous sdhb larvae, and n = 70 WT larvae; 1000 mg⋅L−1 Vitamin C: n = 90 homozygous sdhb larvae, n = 172 heterozygous sdhb larvae, and n = 86 WT larvae from two replicates). No significant differences were observed between sdhb heterozygous and WT siblings at either low or high dosage Vitamin C treatment. Log-rank (Mantel–Cox) test, ** p < 0.01.

Figure Data
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cancers